The surprise small-cap winner from the aged care debacle

Aged care stocks have taken a big hit from the upcoming Royal Commission but there's one small-cap stock that can benefit from the expected reforms to the industry.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

Aged care stocks have taken a big hit from the upcoming Royal Commission into the sector and the negative publicity surrounding their standard of care but there's one small-cap stock that might benefit from the expected reforms to the industry.

The allegations of elderly neglect and abuse are fuelling calls by the industry union for mandatory staff-to-patient ratios at these facilities and that could equate to a $5 billion hit to the sector's bottom line, according to analysis by the Aged Care Guild and reported in the Australian Financial Review.

This is from staffing changes alone. Throw in tighter regulations and you can bet the profit margins for the sector will take a big hit. This is the key reason I am avoiding shares in Japara Healthcare Ltd (ASX: JHC), Regis Healthcare Ltd (ASX: REG) and Estia Health Ltd (ASX: EHE).

These shares are down between 17% and 30% since the start of the calendar year when the S&P/ASX 200 (Index:^AXJO) (ASX: XJO) index is up 2%.

If there was a sector in dire need of automation, it would be aged care. The anticipated painful reforms are likely to be a big catalyst for technology adoption in an industry that is better known for conservatism and sticking to what it knows.

This creates an opportunity for Paragon Care Ltd. (ASX: PGC) in my opinion. I was chatting with an executive from the company about a year ago about the new products it was looking to bring to the Australian market and artificial intelligence (AI) came up.

AI is supposed to drive the next generation of patient care systems and he said that smart cameras that can recognise and anticipate patient needs are already being tested in the field. My contact was convinced that the industry will move quickly to adopt the technology.

The technology will free up staff and can even control other robotics to help with patient care. The elderly may not need a personal assistant to get out of bed or perform other daily functions.

It's a bit futuristic but the technology is certainly available today.

I was less enthusiastic back then. It's not that I don't believe in the technology – I certainly do – but I know there are several regulatory hurdles and mindsets that need to be changed before we see mass adoption of what could be an invasive technology.

Key decision makers must be convinced that there are no shortcomings that could put patient lives at risk (and you can imagine the legal fallout on this front) and you can also bet the unions will be up in arms as the roll-out of AI will mean fewer jobs.

AI will certainly come to a medical facility near you but maybe not in the one-year plus timeframe that my contact believed.

Alas, the change a Royal Commission can bring! I could be the one eating humble pie and I thank my lucky stars that I didn't make a bet to hike to Mt Kosciuszko wearing an embarrassing t-shirt (no names here on who did).

If putting up with a risk to privacy means better outcomes for the elderly, it may be a price society will be willing to pay.

Motley Fool contributor Brendon Lau owns shares of Paragon Care Limited. The Motley Fool Australia has recommended Paragon Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A group of people in a corporate setting do a collective high five.
Healthcare Shares

ASX 300 healthcare stock outperforming today on 'strategic' leadership news

The ASX healthcare stock announced the outcome of its CEO recruitment drive this morning.

Read more »

Cropped shot of a young female scientist working on her computer in the laboratory.
Healthcare Shares

Could Telix shares be a millionaire-maker stock?

Telix looks a compelling growth story, with brokers eyeing more than 150% upside.

Read more »

A child covering his eyes hiding from a toy bear.
Healthcare Shares

Down 20% in 2026, is now the time to buy CSL shares?

CSL shares hit a new multi-year low as the 2026 decline deepens.

Read more »

Scientists in white coats look disappointed.
Healthcare Shares

Down 87% since Thursday, why is this ASX 300 healthcare stock sliding again today?

The ASX healthcare share has plunged more than 87% in five trading days.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Which ASX biotech's shares have jumped more than 10% on positive clinical trial news?

A potential cancer treatment is progressing.

Read more »

Man jumps for joy in front of a background of a rising stocks graphic.
Healthcare Shares

3 ASX healthcare stocks tipped to soar over 100% higher this year

These ASX shares are on my radar this week.

Read more »

Scientists working in the laboratory and examining results.
Opinions

3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »